Pernix Therapeutics Holdings, Inc. (PTX): Price and Financial Metrics


Pernix Therapeutics Holdings, Inc. (PTX): $0.21

-0.01 (-4.55%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PTX Stock Price Chart Interactive Chart >

Price chart for PTX

PTX Price/Volume Stats

Current price $0.21 52-week high $3.30
Prev. close $0.22 52-week low $0.20
Day low $0.20 Volume 1,010,500
Day high $0.24 Avg. volume 2,010,779
50-day MA $0.52 Dividend yield N/A
200-day MA $1.23 Market Cap 3.05M

Pernix Therapeutics Holdings, Inc. (PTX) Company Bio


Pernix Therapeutics Holdings, Inc. develops, manufactures, markets, and sells branded and generic pharmaceutical products. The company’s product include CEDAX, an oral cephalosporin used for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza, or streptococcus pyogene; Zutripro, Rezira, and Vituz for the relief of cough and nasal congestion; and OMECLAMOX-PAK a gastroenterology product. The company was founded in 1996 and is based in Morristown, New Jersey.


PTX Latest News Stream


Event/Time News Detail
Loading, please wait...

PTX Latest Social Stream


Loading social stream, please wait...

View Full PTX Social Stream

PTX Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9686 seconds.